AIxCrypto Holdings, Inc.
AIXC
Rank in Stocks
#26611
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Share Price
$0.9458
Last synced: 2026-11-03
Market Cap
$19.19M
Change (1 day)
-7.27%
Change (1 year)
-65.36%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AIxCrypto Holdings, Inc. (AIXC)
Category
Healthcare
EPS for AIxCrypto Holdings, Inc. (AIXC)
EPS as of June 2026 TTM: $-9.44
According to AIxCrypto Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-9.44. At the end of 2025 the company had an EPS of $-8.11, an increase over its 2024 EPS of $-17.55.
EPS history for AIxCrypto Holdings, Inc. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-9.44 | 16.40% |
| 2025 | $-8.11 | -53.79% |
| 2024 | $-17.55 | -86.73% |
| 2023 | $-132.25 | -45.58% |
| 2022 | $-243.00 | -20.33% |
| 2021 | $-305.00 | -56.76% |
| 2020 | $-705.37 | -94.67% |
| 2019 | $-13.24K | 12,253.00% |
| 2018 | $-107.14 | 236.81% |
| 2017 | $-31.81 | -99.99% |
| 2016 | $-255.00K | -34.41% |
| 2015 | $-388.75K | 688.57% |
| 2014 | $-49.30K | 16.21% |
| 2013 | $-42.42K | -30.59% |
| 2012 | $-61.12K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -117.90% |
US
|
|
| $1.93 | -120.45% |
SE
|
|
| $6.91 | -173.24% |
FR
|
|
| $0.02 | -100.21% |
HK
|
|
| $2.71 | -128.71% |
IT
|
Questions about AIxCrypto Holdings, Inc.'s earnings per share (EPS)
What is AIxCrypto Holdings, Inc.'s earnings per share (EPS)?
AIxCrypto Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-9.44, as of Jun 2026.
What was AIxCrypto Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, AIxCrypto Holdings, Inc.'s earnings per share (EPS) was $-8.11, compared with $-17.55 in 2024.
How has AIxCrypto Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, AIxCrypto Holdings, Inc.'s earnings per share (EPS) was highest in 2025 ($-8.11) and lowest in 2020 ($-705.37).
How does AIxCrypto Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
AIxCrypto Holdings, Inc.'s earnings per share (EPS) ($-9.44) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.